Molecular Biology

B.F. Pugh, R. Tjian, "Mechanism of transcriptional activation by Sp1: evidence for coactivators," Cell, 61:1187-97, 1990. Franklin Pugh (Howard Hughes Medical Institute, University of California, Berkeley): "The story of eukaryotic transcriptional coactivators has provoked a new way of thinking about how sequence-specific activators communicate with the basal transcriptional machinery. "The prevailing thought prior to this work was that the TFIID component of this machine was a single protein

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

B.F. Pugh, R. Tjian, "Mechanism of transcriptional activation by Sp1: evidence for coactivators," Cell, 61:1187-97, 1990.

Franklin Pugh (Howard Hughes Medical Institute, University of California, Berkeley): "The story of eukaryotic transcriptional coactivators has provoked a new way of thinking about how sequence-specific activators communicate with the basal transcriptional machinery.

"The prevailing thought prior to this work was that the TFIID component of this machine was a single protein that was targeted directly by activators. Purified recombinant yeast TFIID seemed to fit the bill because it was a single polypeptide that bound to the TATA box and reconstituted the basal transcription machinery.

"There was one problem with this idea, however. Neither this yeast TATA-binding protein nor its homologs cloned from flies and humans would allow activators to communicate with the basal transcription machinery and activate transcription.

Apparently, there was more to the natural TFIID, namely coactivators, than was contained in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies